Showing results (61-70 of 120) with videos related to

Sort By:
Pageof 12
Life Sciences|January 1, 1995
Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotoninD C Mash, J K Staley, M H Baumann, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1994
High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victimsJ K Staley, W L Hearn, A J Ruttenber, et al.
Neurobiology of Aging|July 1, 1997
Vesicular acetylcholine transporter density and Alzheimer's diseaseS M Efange, E M Garland, J K Staley, et al.
Neurology|April 1, 1993
Felbamate monotherapy for partial-onset seizures: an active-control trialE Faught, R C Sachdeo, M P Remler, et al.
Alcoholism, Clinical and Experimental Research|January 31, 2006
Smoking comorbidity in alcoholism: neurobiological and neurocognitive consequencesDieter J Meyerhoff, Yousef Tizabi, Julie K Staley, et al.
Neuroreport|January 31, 1996
Altered dopamine transporter densities in alcohol-preferring vervet monkeysD C Mash, J K Staley, F M Doepel, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 15, 1997
Expression of LIM protein genes Lmo1, Lmo2, and Lmo3 in adult mouse hippocampus and other forebrain regions: differential regulation by seizure activityG L Hinks, B Shah, S J French, et al.
Neuroscience Letters|June 2, 1995
Properties of ibogaine and its principal metabolite (12-hydroxyibogamine) at the MK-801 binding site of the NMDA receptor complexD C Mash, J K Staley, J P Pablo, et al.
Neurology|October 1, 2010
Changes in fiber tract integrity and visual fields after anterior temporal lobectomyC R McDonald, D J Hagler, H M Girard, et al.
Synapse (New York, N.Y.)|April 13, 2011
Assessing the sensitivity of [¹¹C]p943, a novel 5-HT1B radioligand, to endogenous serotonin releaseKelly P Cosgrove, Tracy Kloczynski, Nabeel Nabulsi, et al.
Pageof 12